/Cell & Gene Therapy Manufacturing & Commercialization US

Cell & Gene Therapy Manufacturing & Commercialization US

23 - 26 September 2024 | Boston, USA

The cell and gene therapy event for ground-breaking manufacturing, commercialization and supply chain strategies


Peter Peumans (CTO Health), will be contributing to the panel discussion, 'distributed/point of care manufacturing for cell therapies: building the ecosystem, overcoming hurdles, etc.', during the 'improving patient outcomes and efficiency with distributed manufacturing' session (as part of the Cell Therapy Manufacturing track).


World renowned leaders share the latest bioprocessing science and technologies to improve manufacturing scalability, cost, and quality to increase access to patients in rare diseases and beyond.

Discover more